Contineum Therapeutics (CTNM) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to $266000.0.
- Contineum Therapeutics' Other Non-Current Assets rose 876666.67% to $266000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $266000.0, marking a year-over-year increase of 876666.67%. This contributed to the annual value of $3000.0 for FY2024, which is 9976.62% down from last year.
- Latest data reveals that Contineum Therapeutics reported Other Non-Current Assets of $266000.0 as of Q3 2025, which was up 876666.67% from $186000.0 recorded in Q2 2025.
- In the past 5 years, Contineum Therapeutics' Other Non-Current Assets ranged from a high of $2.6 million in Q1 2024 and a low of $3000.0 during Q2 2024
- Its 3-year average for Other Non-Current Assets is $546375.0, with a median of $95000.0 in 2025.
- Data for Contineum Therapeutics' Other Non-Current Assets shows a peak YoY increase of 876666.67% (in 2025) and a maximum YoY decrease of 9984.75% (in 2025) over the last 5 years.
- Quarter analysis of 3 years shows Contineum Therapeutics' Other Non-Current Assets stood at $1.3 million in 2023, then crashed by 99.77% to $3000.0 in 2024, then skyrocketed by 8766.67% to $266000.0 in 2025.
- Its last three reported values are $266000.0 in Q3 2025, $186000.0 for Q2 2025, and $4000.0 during Q1 2025.